Back to mobile site

More on CMPX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.4 Score)

Upcoming Events

- Earnings (8/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Compass Therapeutics, Inc (NQ:CMPX)
Delayed: 2.02 -0.03 (1.46%)
Prev. Close $2.05  
Open$2.08 
52 Wk High$ 
52 Wk Low$ 
Day High$2.13 
Day Low$2.00 
P/E N/A  
EPS$ 
Volume9,276,475 

Friends, Peers and Foes (?): ABBV, AMGN, ARGX, ARWR, AVTX (more...)

Jun 12, 2026 08:10 AM After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
Jun 11, 2026 04:01 PM Form 8-K Compass Therapeutics, For: Jun 10
Jun 4, 2026 05:22 AM Compass Therapeutics (CMPX) Reiterated at Market Outperform by Citizens
Jun 1, 2026 07:32 AM Compass Therapeutics (CMPX) Reiterated at Buy by Stifel After ASCO Presentation
May 28, 2026 07:30 AM Compass Therapeutics to Participate in Upcoming June Investor Events
May 21, 2026 05:00 PM Compass Therapeutics reports phase 1 data for CTX-8371 at ASCO meeting
May 21, 2026 05:00 PM Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting
May 15, 2026 04:12 PM Form SCHEDULE 13G/A Compass Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
May 12, 2026 07:30 AM Compass Therapeutics to Participate in Upcoming May Investor Events
May 5, 2026 08:01 AM Form 10-Q Compass Therapeutics, For: Mar 31
View All Articles

Entities mentioned with CMPX

View All Entities